Clinical Trial Update: The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China

View source ↗

Summary

A real-world study evaluating a BTK inhibitor for chronic lymphocytic leukemia in China; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• BTK inhibitor (unspecified)

Snippet

Sponsor: Peking University People's Hospital | Conditions: CLL | Status: NOT_YET_RECRUITING